Evaluation of a potential drug interaction between sucralfate and aspirin

Clinical Pharmacology and Therapeutics
A H LauP K Schlesinger

Abstract

Recent studies have demonstrated a cytoprotective effect of sucralfate on gastric mucosa in patients receiving aspirin. The potential drug interaction between sucralfate and aspirin was evaluated in a randomized crossover manner in 12 healthy men. Subjects were initially given a single dose of aspirin alone or in combination with sucralfate for 2 days. The drug dosing schedule was then reversed after 1 week. Sixteen blood samples were drawn after each aspirin dose for HPLC assay of aspirin and its metabolites. Pharmacokinetic parameters were calculated for aspirin, salicylic acid, and salicyluric acid. None of these parameters demonstrated any statistically significant differences between the two treatment groups. The combined use of sucralfate and aspirin is therefore not likely to result in a clinically significant pharmacokinetic drug interaction. The systemic therapeutic effect of aspirin is not expected to be altered when sucralfate is used concurrently in patients receiving chronic aspirin therapy.

Citations

Jun 1, 1991·DICP : the Annals of Pharmacotherapy·A D Van SlootenH R Goldstein
Apr 1, 1991·Journal of Clinical Pharmacology·D K SchneiderP A DeFusco
Apr 18, 2016·European Journal of Drug Metabolism and Pharmacokinetics·Suresh P SulochanaNuggehally R Srinivas
Jan 1, 1989·Antimicrobial Agents and Chemotherapy·S H ParpiaJ J Schentag
Jan 1, 1987·Pharmacology & Therapeutics·R O DayJ de Jager
Aug 1, 1988·Baillière's Clinical Rheumatology·A L Tonkin, L M Wing

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.